How to evaluate a female patient complaining of dyspareunia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation of Female Patients with Dyspareunia

The evaluation of dyspareunia should begin with a thorough assessment of pain characteristics (location, timing, quality), followed by a targeted physical examination to identify specific causes such as vulvodynia, vaginal atrophy, inadequate lubrication, pelvic floor dysfunction, or endometriosis.

Initial Assessment

  • Create a safe and welcoming environment for discussing sexual health concerns, as patients may feel uncomfortable sharing these intimate details 1
  • Obtain a detailed pain history including:
    • Location (entry/superficial vs. deep) 2
    • Timing (primary vs. acquired) 1
    • Quality (burning, sharp, aching) 1
    • Relationship to sexual activity (before, during, after) 2
  • Assess for contributing factors:
    • Inadequate lubrication 1
    • Hormonal status (menopause, breastfeeding) 3
    • Medication effects 1
    • History of trauma or sexual assault 4
    • Relationship factors 2

Physical Examination

External Genital Examination

  • Perform visual inspection of the vulva for:
    • Erythema, lesions, or anatomical abnormalities 1
    • Signs of dermatologic conditions 1
  • Conduct cotton swab test:
    • Apply sequential pressure with cotton swab to vulvar vestibule 1
    • Map areas of tenderness to identify focal pain 1

Vaginal Examination

  • Single-digit examination to assess:
    • Pelvic floor muscle tone and tenderness 1
    • Vaginal atrophy (thinning, pallor, decreased rugae) 3
    • Presence of scarring or stenosis 4
  • Speculum examination to evaluate:
    • Vaginal discharge or infection 4
    • Cervical abnormalities 4

Bimanual Examination

  • Assess for:
    • Uterine position (retroversion) 1
    • Adnexal masses or tenderness 2
    • Pelvic floor muscle spasm 1
    • Tenderness suggestive of endometriosis or pelvic inflammatory disease 4

Common Diagnoses and Specific Evaluation

Vulvodynia

  • Characterized by burning pain at the vaginal entrance 1
  • Positive cotton swab test with localized tenderness 2
  • Rule out infectious causes with appropriate cultures 4

Vaginal Atrophy

  • Common in postmenopausal women or those on certain medications 3
  • Physical findings include pale, thin vaginal tissue with decreased rugae 3
  • May affect up to 40% of postmenopausal women 3

Inadequate Lubrication

  • Often associated with hormonal changes, medications, or insufficient arousal 1
  • Assess for vaginal dryness during examination 1

Pelvic Floor Dysfunction

  • Characterized by involuntary muscle spasm (vaginismus) 1
  • May be primary or secondary to other painful conditions 2
  • Assess for muscle tenderness and spasm during single-digit examination 1

Endometriosis

  • Consider in women with deep dyspareunia and cyclic pelvic pain 1
  • Tenderness on examination, especially with uterine mobility 4
  • May require laparoscopy for definitive diagnosis 4

Pelvic Inflammatory Disease (PID)

  • Consider in women with risk factors for sexually transmitted infections 4
  • Evaluate for minimum criteria: lower abdominal tenderness, adnexal tenderness, and cervical motion tenderness 4
  • Additional criteria include fever, abnormal discharge, elevated inflammatory markers 4

Special Considerations

Postmenopausal Women

  • Evaluate for vulvovaginal atrophy, which affects up to 40% of postmenopausal women 3
  • Consider the role of estrogen deficiency in symptom development 3
  • Assess for other age-related changes that may contribute to pain 4

Cancer Survivors

  • Women with history of pelvic cancer treatment may experience treatment-related dyspareunia 4, 5
  • Evaluate for radiation-induced changes, surgical scarring, or hormone therapy effects 4, 5
  • Consider the psychological impact of cancer diagnosis and treatment on sexual function 4

Transgender and Gender-Diverse Patients

  • Use trauma-informed approach to examination 4
  • Consider unique factors such as chest binding, genital tucking, or gender-affirming surgeries 4
  • Be aware of higher rates of sexual assault and trauma in this population 4

Laboratory and Additional Testing

  • Consider testing for:
    • Vaginal infections (wet mount, cultures) 4
    • Sexually transmitted infections when indicated 4
    • Hormonal status in perimenopausal or menopausal women 3
  • Additional testing based on suspected etiology:
    • Pelvic ultrasound for suspected structural abnormalities 2
    • Laparoscopy for suspected endometriosis 4
    • Referral to specialist for complex cases 6

Clinical Pitfalls to Avoid

  • Failing to screen for dyspareunia due to discomfort with sexual health topics 6
  • Attributing all sexual pain to psychological causes without adequate physical evaluation 2
  • Missing comorbid conditions that may contribute to pain (e.g., interstitial cystitis, irritable bowel syndrome) 2
  • Overlooking the impact of medications on sexual function 1
  • Neglecting to assess for history of sexual trauma, which may influence both symptoms and response to examination 4

References

Research

Dyspareunia in Women.

American family physician, 2021

Research

Evaluation and differential diagnosis of dyspareunia.

American family physician, 2001

Research

Vaginal estrogens for the treatment of dyspareunia.

The journal of sexual medicine, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ovarian Cancer and Vulvovaginal Atrophy Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Female Sexual Health: Screening and Evaluation.

Obstetrics and gynecology clinics of North America, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.